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Abstract
Regional cortical thickness alterations have been reported in many chronic inflammatory and painful conditions, including
inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS), even though the mechanisms underlying such
neuroplastic changes remain poorly understood. In order to better understand the mechanisms contributing to grey matter
changes, the current study sought to identify the differences in regional alterations in cortical thickness between healthy
controls and two chronic visceral pain syndromes, with and without chronic gut inflammation. 41 healthy controls, 11 IBS
subjects with diarrhea, and 16 subjects with ulcerative colitis (UC) underwent high-resolution T1-weighted magnetization-
prepared rapid acquisition gradient echo scans. Structural image preprocessing and cortical thickness analysis within the
region of interests were performed by using the Laboratory of Neuroimaging Pipeline. Group differences were determined
using the general linear model and linear contrast analysis. The two disease groups differed significantly in several cortical
regions. UC subjects showed greater cortical thickness in anterior cingulate cortical subregions, and in primary
somatosensory cortex compared with both IBS and healthy subjects. Compared with healthy subjects, UC subjects showed
lower cortical thickness in orbitofrontal cortex and in mid and posterior insula, while IBS subjects showed lower cortical
thickness in the anterior insula. Large effects of correlations between symptom duration and thickness in the orbitofrontal
cortex and postcentral gyrus were only observed in UC subjects. The findings suggest that the mechanisms underlying the
observed gray matter changes in UC subjects represent a consequence of peripheral inflammation, while in IBS subjects
central mechanisms may play a primary role.
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Introduction
Inflammatory bowel diseases (IBD) such as ulcerative colitis
(UC) are characterized by chronically recurring symptoms of
abdominal pain associated with flares of mucosal inflammation. In
contrast, in irritable bowel syndrome (IBS), chronically recurring
symptoms of abdominal pain and discomfort occur in the absence
of mucosal inflammation or other identifiable nociceptive triggers
(therefore referred to as ‘‘functional’’ pain syndromes), and
symptom flares are often triggered by psychosocial stressors. It is
generally assumed that abdominal pain in UC results initially from
inflammation induced peripheral and central sensitization of
visceral afferent pathways [1], while symptoms in IBS may reflect
primarily an alteration in central pain modulation, including
alterations in endogenous descending pain modulation mecha-
nisms [2]. On the other hand, several pieces of evidence support
the concept that IBD patients effectively engage endogenous pain
inhibition systems [3], including greater engagement of a cortico
limbic-pontine pain modulation network compared to IBS subjects
[4]. These differences in the engagement of endogenous pain
modulation systems may explain the clinical observation that in
uncomplicated UC, abdominal pain is not a prominent symptom
even during flares.
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Several studies have applied multimodal brain imaging to
investigate the presence of grey matter changes in patients with
various chronic pain conditions without known nociceptive drive
[5–9], with presumed nociceptive drive [10–12], and with known
inflammatory drive [13–18]. Reported abnormalities in these
studies suggest some similarities in findings (e.g. gray matter
reduction in insula [INS] and anterior cingulate cortex [ACC]
subregions), and increases in CT in somatosensory regions
regardless of pain syndrome, and no clear differences have
emerged between the different pain categories, in particular
between chronic visceral pain of ‘‘functional’’ and of inflammatory
origin. The use of different analysis techniques by different groups,
makes interpretive comparisons between studies and between
different patient populations more difficult.
In the current study, we used the Laboratory of Neuroimaging
(LONI) Pipeline [19,20] for image preprocessing, volumetric
analysis and cortical thickness (CT) analysis. We focused on
differences of local morphologic brain alterations between UC
and healthy control subjects (HCs), and compared them to
findings in IBS subjects. Specifically, we aimed to test the
following hypotheses: 1) Both IBS and UC patients differ from
HCs in terms of regional CT changes. 2) UC patients show CT
changes in brain regions involved in somatosensory and
viscerosensory processing and modulation. 3) IBS patients show
CT changes in brain regions involved in the integration of
affective, cognitive and interoceptive signals. 4) In UC patients,
there are correlations between CT changes and duration of gut
inflammation, reflecting the chronic influence of peripheral
inflammation on the brain.
Materials and Methods
Subjects
A total 68 right-handed male and female subjects were recruited
through the UCLA Digestive Disease Clinic and advertisements
including HCs (n= 41; mean age= 28.2 years old, range = 19–
48 years; 16 males), IBS with diarrhea (n= 11; mean age = 31.6 -
years old, range= 21–47 years; 2 males), and UC subjects (n = 16;
mean age = 28. 6 years old, range 18–48 years; 10 males). 15 HCs
and 5 IBS subjects of the respective samples have been included in
a previously published gray matter volume analysis [9]. Exclusion
criteria for all subjects comprised pregnancy, postpartum or
nursing females, current substance abuse or dependence, abdom-
inal surgery, any past or present neurological illness or trauma,
claustrophobia or learning disability, and current psychiatric
diagnosis. A diagnosis of IBS was made by a gastroenterologist or
nurse practitioner with expertise in functional GI disorders based
on the ROME II or ROME III symptom criteria during a clinical
assessment [21,22]. The diagnostic criteria include recurrent
abdominal pain or discomfort associated with two or more of the
following: 1) pain/discomfort is relieved/improved by defecation
2) the onset of pain/discomfort is related to a change in frequency
of stool 3) the onset of pain/discomfort is related to a change in the
form (appearance) of stool. In order to match the predominant
bowel habit of UC patients, only IBS patients with diarrhea were
used in this study. In addition, IBS subjects with current regular
use of analgesic drugs (including narcotics, opioids and alpha2-
delta ligands) were excluded. UC patients were diagnosed by a
gastroenterologist, which was supported by biopsies obtained by
endoscopy. During screening, all subjects completed the modified
Mayo UCDAI (disease activity index for Stool frequency, rectal
bleeding and physician rating of disease activity) to assess degree of
current disease. A score of 0–1 is considered Remission, score of
2–4 mild disease, and .4 is considered active disease [23].
Exclusion criteria specific to the UC population were corticoste-
roid use within last 6 months, or use of any psychotropic
medications. All procedures were approved by the UCLA Medical
Institutional Review Board, and all subjects provided written
informed consent. Questionnaires were completed before scanning
to determine symptom type, severity, duration of symptoms, and
abdominal sensation (UCLA Bowel Symptom Questionnaire,
BSQ) [24], comorbid affective and mood disorders (Hospital
Anxiety Depression Scale, HAD) [25], and IBS-related fears and
anxiety (Visceral Sensitivity Index, VSI) [26,27]. Details are shown
in Table 1.
Structural MRI Acquisition
All high-resolution T1-weighted brain images were collected at
the UCLA Brain Mapping Center using a Siemens 3 Tesla Trio
with magnetization prepared rapid gradient echo scanning
parameters (TR=2200 ms, TE=3.26 ms, flip angle = 9u, dur-
ation= 9:03 mins, FOV=256).
Data analysis
We employed the LONI pipeline for image preprocessing,
cortical surface modeling and gray matter thickness analysis
[19,20]. Following a de-identification step, the structural neuro-
imaging data were converted from Digital Imaging and Commu-
nications in Medicine to ANALYZE 7.5 format, skull-stripped
using the LONI Skull-Stripping Meta Algorithm pipeline work-
flow [28] and cortical surface models were generated using
FreeSurfer 4.0 [29] (http://surfer.nmr.mgh.harvard.edu/fswiki
and http://ucla.in/xSQPqT). Cortical grey matter thickness was
computed at each point of the surface using the distance from the
pial surface to the nearest point on the white matter surface. For
numerical implementation, we first built the signed distance
function [30,31] of the white matter surface in 3D space and then
computed the CT as the value on the signed distance function at
those locations. The cortical surfaces and the corresponding CT
maps were registered to the International Consortium for Brain
Mapping (ICBM) brain surface [32] and then vertex-wise
correspondences were established between all cortical surface
models using a Conformal Metric Optimization method [33]. An
experienced human brain researcher rated each brain surface
reconstruction by visually inspecting the surfaces using LONI
ShapeViewer (http://www.loni.ucla.edu/Software/
ShapeViewer). The quality of surface reconstruction and accuracy
of vertex labeling were assessed on the scale of 0 to 1
(0 = completely unacceptable; 1 = perfectly reconstructed and
labeled). A threshold of 0.7 was selected as the criterion to
reconstruct a subject’s surface data to be included in the final
analysis.
Region of interest analysis
We examined the CT change in several manually delineated
regions of interest (ROIs) in each hemisphere based on previous
studies [11,14,34–39]. These ROIs included insular subregions
(anterior INS [aINS], mid INS [mINS], and posterior INS
[pINS]), cingulate subregions (subgenual ACC [sgACC], pregen-
ual ACC [pgACC], anterior midcingulate cortex [aMCC] and
posterior MCC [pMCC]), orbitofrontal gyrus (OFG) (lateral
OFG and medial OFG), pre- and postcentral gyri [32]. No
subregions of pre- and postcentral gyri were drawn. The
subregions of INS and cingulum were manually delineated on
the 3D ICBM brain atlas [32] by two well-trained researchers
with good command of neuroanatomical knowledge (Figure S1).
The 3D ROI masks were transformed back onto the ICBM
Brain Alterations in Patients with Visceral Pain
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surface space by resampling the atlas map based on masks’
Euclidean coordinates [33].
Statistical analysis
To determine potential protocol differences in ROIs, a general
linear model (GLM) was applied to examine differences in total
gray matter volumes within HCs as a function of protocol. Group
differences in CT within ROIs as a function of group, sex and
group*sex were determined using the GLM and weighted linear
contrast analysis controlling for total gray matter volume, and age
in SPSS v19. The contrasts testing the interaction between group
and sex were weighted to eliminate any bias caused by unbalanced
representation of sexes. Although this was a hypothesis driven
study, we implemented a conservative procedure to adjust for
multiple comparisons in order to control for type I error.
Specifically, the false-discovery rate (FDR) for the 66 contrasts
(11 bilateral ROIs [n = 22] for each of three independent
contrasts) was held at 5% [40–42]. GLM and linear contrast
analysis controlling for sex and age were also applied to examine
differences in BSQ between IBS and UC subjects as well as group
differences in non-BSQ clinical and behavioral characteristics
including VSI and HAD. Significance was determined after
controlling FDR at 5% [40,41].
Correlation Analysis of Clinic Variables
Within group exploratory partial correlation analyses control-
ling for total gray matter volume, sex, and age were performed to
characterize the association between subjects’ clinic characteris-
tics (BSQ, VSI, HAD and Mayo UCDAI) and regions showing
significant group differences in CT. However, for the partial
correlation between significant ROIs and symptom duration, we
did not include age as a covariate, as these explanatory variables
were significantly correlated, for IBS group (duration, r = .39,
p = .036), and for UC group (duration, r = .67, p= .001) [43].
Significance was determined after controlling FDR at 5%
[40,41].
Results
Subject Characteristics
Subjects’ clinical data are summarized in Table 1. Compared to
the HCs, the two disease groups showed significantly higher
measures of symptom related anxiety (VSI scores: IBS.HCs,
F= 126.28, p,.001; UC.HCs, F= 71.97, p,.001; IBS.UC,
F= 10.61, p = .002), anxiety symptoms (HAD scores: IBS.HCs,
F= 17.03, p,.001; UC.HCs, F= 28.02, p,.001), and depression
symptoms (HAD scores: IBS.HCs, F= 4.88, p = .031; UC.HCs,
F= 15.16, p,.001). IBS subjects had significantly higher overall
bowel symptoms scores, more abdominal discomfort and pain
than UC subjects. Using the Mayo UCDAI [23], 5 of the UC
subjects were in remission, 7 had mild disease and 4 had active
disease (mild flare). There were no differences in terms of age of
subjects and duration of GI symptoms.
Regional Cortical Thickness Changes Using ROI Analysis
Regional CT differences were observed between UC, IBS and
HCs. Mean CT values and statistical significance after FDR
correction are shown in Table 2 and Table S1. As depicted in
Figure 1A, compared to both IBS and HCs, UC subjects showed
greater CT in left cingulate cortical subregions (aMCC, pMCC,
pgACC and sgACC), and in left post central gyrus (statistically
significant differences following FDR correction for multiple
comparisons are shown in Figure 1A and marked with asterisks).
As shown in Figure 1B, compared to both IBS and HCs, UC
subjects had reduced CT in prefrontal regions (left medial and
lateral OFG) and in left INS subregions (most significant in pINS).
Following FDR correction for multiple comparisons, the results
between HCs and UC remained significant even though some
differences (OFG and INS) between IBS and UC groups were no
longer significant (significant differences are shown in Figure 1B
and marked with asterisks). All results remained significant after
controlling for depression. However, after controlling for anxiety,
the observed differences between HCs and UC subjects in left
pMCC, aINS and mINS were no longer significant after FDR
Table 1. Clinical and behavioral characteristics.
HCs IBS subjects UC subjects F Sig.
N Mean SD N Mean SD N Mean SD
Sex (Male/Female) 16/25 2/9 10/6
Age 41 28.17 8.43 11 31.55 9.49 16 28.56 8.95 .66 .52
Anxiety symptoms1 41 2.8 2.33 11 6.91 3.67 16 7.31 3.55 18.29 ,.01
Depression symptoms1 41 .85 1.22 11 2.64 2.73 16 3.44 3.54 7.77 ,.01
Visceral Sensitivity Index 2 40 2.83 5.17 11 37.45 12.94 15 26.13 14.09 61.68 ,.01
Overall Bowel Symptoms3 11 11.91 2.74 13 4.69 2.46 54.12 ,.01
Abdominal Pain4 11 10.55 4.3 14 4.14 3.61 18.01 ,.01
Abdominal Discomfort5 11 11.91 4.21 16 4.06 3.86 49.63 ,.01
Duration of symptoms6 10 8.5 6.13 16 9.81 9.35 1.67 .69
F = main effect of group from ANOVA and t-tests for four and two group comparisons, respectively.
1. HAD: Hospital Anxiety and Depression [25];
2. VSI: Visceral Sensitivity Index [26,27];
BSQ: Bowel Symptom Questionnaire [24].
3. BSQ Overall Symptoms in the Past week (0–20).
4. BSQ Abdominal Pain in the Past week (0–20).
5. BSQ Discomfort in the Past week (0–20).
6. BSQ Duration in years, derived from onset of symptom.
Statistically significant p,0.05.
doi:10.1371/journal.pone.0084564.t001
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correction (Table 2). As shown in Figure 1C, compared to HCs,
IBS subjects showed significantly reduced CT in right aINS after
FDR correction, a difference that was not affected by controlling
for anxiety and depression.
Correlation of Cortical Thickness with Behavioral and
Clinical Variables
In the UC group, symptom duration was negatively correlated
with CT in left lateral OFG (r =2.88, p = .0002, q = .0006,
Figure 2A) and left medial OFG (r =2.78, p = .003, q = .003,
Figure 2B) and was positively correlated with CT in left postcentral
gyrus (r = .77, p = .003, q= .003, Figure 2C). Adding anxiety and
depression scores as covariates did not alter the results. No
significant correlations with other clinical parameters (including
the Mayo UCDAI) were observed.
Discussion
The primary goal of the current study was to assess regional
CT differences between subjects with UC, and two comparison
groups: a healthy control group and a disease control group
without gut inflammation (IBS).The main findings of the study
were: 1) Compared to both IBS and HCs, UC subjects showed
greater CT in left cingulate cortical subregions, and in left primary
somatosensory cortex (SI). 2) Compared with HCs, UC subjects
showed lower CT in left OFG and in primary viscerosensory
cortex (pINS). 3) Compared to HCs, IBS subjects showed lower
CT in the interoceptive association cortex (aINS) in the right
hemisphere. 4) There were large significant correlations of CT
reductions in left OFG and CT increases in left SI with symptom
duration in UC subjects, suggesting a role of chronic inflamma-
tion driven afferent input in these changes. The emerging pattern
highlights significant differences in CT between patients with
chronic gut inflammation, functional GI disorders and HCs, as
well as some similarities.
Figure 1. Mean cortical thickness of the ROIs showing significant group differences. (A) UC subjects showed the greatest CT in the regions
of somatosensory and cingulate cortex. (B) In the subregions of OFG and INS, UCs had lower CT compared with HCs. (C) IBS subjects had lower CT in
right aINS compared to HCs. Error bars reflect standard deviation. Asterisk indicates significant differences between groups (q,0.05) after controlling
for sex, age, total gray matter volume and FDR correction.
doi:10.1371/journal.pone.0084564.g001
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Greater Regional CT in UC Patients
Somatosensory Cortex. In the current study, greater CT in
primary somatosensory cortex (SI) was seen in the UC group. SI is
part of the central pain processing network and its thickness is
positively correlated with individual experimentally induced acute
pain sensitivity in healthy subjects [44,45]. Chronic pain in human
patient populations has been shown to be associated with cortical
reorganization and changes in SI activity [38,46,47]. For example,
SI cortical thickening has been reported in patients with migraine
[48] and temporomandibular pain [43]. It has been suggested that
the critical factor for S1 to undergo structural reorganization may
be the presence of constant sensory input to this brain region
[38,43,47]. Additionally, a voxel based morphometry study
showed increased left pre- and postcentral gyri in chronic back
pain patients [39]. In the current study, CT of left postcentral
gyrus in UC groups showed a large positive correlation with
symptom duration, consistent with a possible etiologic role of
chronically enhanced viscerosensory input to the brain due to
sensitization of visceral afferent pathways by chronic mucosal
inflammation. However, the degree of somatosensory cortex
changes did not correspond to the subjective pain reports, as
UC subjects had greater CT in somatosensory cortex, but reported
lower abdominal pain and discomfort compared to patients with
IBS. Even though the reason(s) for these apparent discrepancies
Table 2. Significant cortical thickness differences in the ROIs between HCs, IBS and UC subjects with and without controlling for
anxiety and depression scores.
ROI Difference F P value q value F(A) q(A) F(D) q(D)
lOFG L HC.UC 23.736 ,.00001 .00023 15.898 .00411 23.592 .00020
lOFG R HC.UC 15.778 .00019 .00160 9.971 .01654 14.000 .00275
HC.IBS 17.591 .00009 .00086 12.647 .00925 17.184 .00102
mOFG L HC.UC 23.124 .00001 .00023 13.904 .00715 26.905 .00009
mOFG R HC.IBS 9.052 .00383 .01686 8.744 .02156 9.802 .01304
Post L UC.HC 9.895 .00258 .01216 9.397 .01966 17.446 .00102
UC.IBS 11.701 .00113 .00678 11.859 .01001 15.595 .00155
aINS L HC.UC 6.701 .01207 .04193 2.234 .26245 7.698 .02568
aINS R HC.IBS 18.098 .00007 .00082 12.384 .00925 16.893 .00102
mINS L HC.UC 10.304 .00213 .01173 3.859 .14306 12.453 .00489
pINS L HC.UC 30.701 ,.00001 .00005 19.658 .00150 29.416 .00008
aMCC L UC.HC 18.231 .00007 .00008 11.277 .01137 18.651 .00080
UC.IBS 19.862 .00004 .00006 19.387 .00150 21.006 .00040
pMCC L UC.HC 8.870 .00042 .01724 2.278 .26245 11.277 .00758
UC.IBS 7.831 .00690 .02677 7.666 .03185 9.082 .01568
pgACC L UC.HC 11.713 .00112 .00678 8.839 .02156 8.901 .01607
UC.IBS 10.127 .00232 .01175 10.014 .01654 9.690 .01304
sgACC L UC.HC 11.754 .00110 .00678 8.692 .02156 9.611 .01304
UC.IBS 7.704 .00734 .02690 7.609 .03185 7.559 .02611
R: right; L: left; lOFG: lateral orbitofrontal gyrus; mOFG: medial orbitofrontal gyrus; Post: postcentral gyrus; aINS: aINSula; mINS: mid insula; pINS: posterior insula; aMCC:
anterior mid cingulate cortex; pMCC: posterior mid cingulate cortex; pgACC: pregenual anterior cingulate cortex; sgACC: subgenual anterior cingulate cortex; q value: p
value after FDR corrected at 5%, q value ,.05 was considered significant; F(A): F score after controlling for anxiety; q(A): corrected p value after controlling for anxiety;
F(D): F score after controlling for depression; q(D): corrected p value after controlling for depression.
doi:10.1371/journal.pone.0084564.t002
Figure 2. Correlation between cortical thickness and UC symptom duration. (A) Cortical thickness in left lateral orbitofrontal gyrus (L_lOFG)
and (B) left medial orbitofrontal gyrus (L_mOFG) were negatively correlated with symptom duration in UC group. (C) Cortical thickness in left
postcentral gyrus (L_Post) showed large positive correlation with UC symptom duration.
doi:10.1371/journal.pone.0084564.g002
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between CT differences in SI and subjective pain reports are not
known, one may speculate that the subjective experience of
chronic clinical visceral pain (as opposed to acute experimentally
induced pain) is more related to activity and related structural
changes in interoceptive association cortex (e.g. the aINS), rather
than to primary sensory cortex [4,49].
Midcingulate Cortex. In the current study, compared to
HCs and IBS subjects, the UC subjects had greater CT in
subregions of the cingulate cortex, e.g. aMCC and pMCC. MCC
is involved in emotion processing, skeletomotor regulation, chronic
somatic and visceral pain, and along with the aINS (as part of the
‘‘salience network’’) integrating information to form conceptual
pain [50–54]. Several studies have reported abnormal MCC
activation by acute noxious visceral stimulation in IBS subjects
[55–58]. Supporting a possible effect of repeated nociceptive
stimuli on MCC structure, repeated application of thermal pain
stimuli to healthy subjects over a period of 8 days resulted in gray
matter increases in both MCC and SI [59]. Together with the
observed greater CT in SI, the findings in UC patients are most
consistent with the presence of a constant sensory input from the
gut, due to sensitization of visceral afferent pathways by chronic
mucosal inflammation. This interpretation is also consistent with
the fact that in the current study, the IBS group (e.g. without
chronically recurring mucosal inflammation) did not show
significant CT change compared to HCs. Further support for
differential brain mechanisms underlying chronic visceral pain
comes from a recent PET ligand study which showed differences
in neurokinin-1 receptor (NK-1R) binding potential (e.g. receptor
availability) between patients with IBD (including Crohn’s disease
and UC) and IBS subjects [60]. Compared to HCs, IBD patients
had low NK-1R availability in ACC and MCC, while IBS showed
this deficit to a lesser extent. Animal studies have shown that the
substance P/NK-1R signaling system is involved in cytogenesis,
has neurotrophic and neuroprotective functions and inhibits
apoptosis [61–63]. This implies a differential involvement of such
neuroplastic mechanisms in the two visceral pain syndromes. Our
findings differ from those reported in two other chronic
inflammatory conditions, e.g. Crohn’s disease [14] and osteoar-
thritis [64]. In both of these studies lower gray matter in the MCC
was observed compared to HCs. Differences in patient populations
and analysis methodology make it difficult to directly compare
these studies with the current report [14,64].
Reduced Regional CT in IBS and UC Patients
INS Subregions. When compared to HCs, both disease
groups showed lower CT in the INS, albeit in different subregions.
Several studies in patients with chronic pain including IBS
[7,9,12,13,64–68] compared to HCs, have found lower gray
matter volumes and CT in the INS, even though subregions were
often not specified. In the current study, UC compared to HCs
had significantly reduced CT in the left pINS (observed differences
in mINS were no longer seen after controlling for anxiety). It is
likely that chronically enhanced afferent input from the gut due to
recurrent mucosal inflammation is primarily associated with CT
changes in the pINS, which represents the primary interoceptive
cortex [37,69]. Even though there was no significant correlation
between symptom duration or other behavioral measures with CT
changes in the pINS, a chronic low back pain study showed that
recovery of CT in pINS (and secondary somatosensory cortex) was
correlated with reduction of pain intensity after treatment [12],
implicating chronic nociceptive and inflammation related signal-
ing as a factor in these CT changes.
In contrast to the UC group, IBS subjects had lower CT in a
different subregion of the INS, e.g. the right aINS compared to
HCs. The aINS functions as interoceptive association cortex
integrates interoceptive input with emotional, salient and cognitive
inputs, and provides output to autonomic and pain modulation
systems [37,53,69–71]. The aINS also plays a central role in
prediction, error processing, and self awareness of sensations
[37,71]. Even though both patient groups had greater affective
scores compared to HCs, IBS subjects reported more abdominal
pain and discomfort compared to the UC group. However, there
was no significant correlation of the observed changes with
affective measures, symptom scores or duration of symptoms in
IBS subjects.
Orbitofrontal Gyrus. UC subjects compared to HCs
showed lower CT in the bilateral OFG, a brain region which
plays an important role in interoception, emotion evaluation and
regulation, and in cognitive reappraisal [43,72,73]. Decreased
gray matter in OFG has also been found in other chronic pain
disorders with inflammatory/nociceptive drive including hip
osteoarthritis [64], low back pain [39] and migraine [74]. A
negative correlation between left OFG thickness and symptom
duration was observed in UC subjects, suggesting a role of chronic
nociceptive input in the observed CT reductions. In contrast, no
such correlation between IBS symptom duration and OFG
structure were observed.
Limitations
Limitations of the study include the small sample size of the IBS
and UC population, the group differences in level of anxiety and
depression symptoms, and the heterogeneity of the groups in terms
of sex. However, controlling for anxiety and depression, most of
the observed results remained significant. In addition, our GLM
and linear contrast were weighted to eliminate any bias caused by
umbalanced representation of sexes. Furthermore, the fact that
large correlations of some structural changes with disease duration
were observed in the UC subjects, and the fact that some of the
findings were similar to reports in subjects with other chronic
inflammatory conditions [13,64], makes it unlikely that the
findings are confounded by these limitations. Future, longitudinal
studies in larger patient populations, including the correlation of
plasma and mucosal inflammatory disease markers with structural
brain changes both during disease flares and remissions are needed
in order to better understand the role of colonic inflammation in
remodeling of the brain. In such larger studies, presence of
comorbidities in the IBS group, as well as differences in the impact
of the IBS and UC on daily life activities and social interactions
should be taken into account.
Conclusions
To our knowledge, this study represents the first comparison of
brain structure between UC patients and both HCs and IBS
subjects. The findings demonstrate significant differences in CT
between UC and HC subjects, and differences between the two
disease groups. Based on the correlation of structural changes with
symptom duration in IBD, one may speculate that the observed
gray matter reorganization of IBD subjects represents a conse-
quence of chronic viscerosensory input to the brain due to
sensitization of visceral afferent pathways by recurrent gut
inflammation. The mechanisms by which such increased viscero-
sensory to the brain input can produce both increases and
decreases of grey matter in different brain regions remains to be
determined.
Brain Alterations in Patients with Visceral Pain
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e84564
Supporting Information
Figure S1 Manually delineated subregions of interest on the 3D
International Consortium for Brain Mapping brain atlas. (A)
Subregions of cingulate cortex: anterior mid cingulate cortex
(aMCC), posterior mid cingulate cortex (pMCC), pregenual
anterior cingulate cortex (pgACC) and subgenual anterior
cingulate cortex (sgACC). (B) Subregions of insula: aINSula
(aINS), mid insula (mINS) and posterior insula (pINS).
(TIF)
Table S1 Mean cortical thickness.
(DOCX)
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